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African Sleeping SicknessThe antiparasitic property of peptides is believed to be associated with their interactions with the protozoan
membrane, which calls for research on the identiﬁcation of membrane sites capable of peptide binding. In this
studywe investigated the interaction of a lipophilic glutathioinepeptide known to be effective against theAfrican
Sleeping Sickness (ASS — African Trypanosomiasis) and cell membrane models represented by Langmuir
monolayers. It is shown that even small amounts of the peptide affect themonolayers of somephospholipids and
other lipids, which points to a signiﬁcant interaction. The latter did not depend on the electrical charge of the
monolayer-forming molecules but the peptide action was particularly distinctive for cholesterol +
sphingomyelinmonolayers that roughly resemble rafts on a cellmembrane. Using in situ polarization-modulated
infrared reﬂection absorption spectroscopy (PM-IRRAS), we found that the orientation of the peptide is affected
by the phospholipids and dioctadecyldimethylammonium bromide (DODAB), but not inmonolayers comprising
cholesterol + sphingomyelin. In this mixed monolayer resembling rafts, the peptide still interacts and has some
induced order, probably because the peptide molecules are ﬁtted together into a compact monolayer. Therefore,
the lipid composition of the monolayer modulates the interaction with the lipophilic glutathioine peptide, and
this may have important implications in understanding how the peptide acts on speciﬁc sites of the protozoan
membrane.275-09972-270-Diadema, SP,
evier OA license.© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
The synthesis and identiﬁcation of small peptides to serve as drugs
for neglected diseases has received increased attention [1], as have
antiparasitic peptides [2–4] shown to act against the ﬂagellated
protozoan, t. rhodescience, the causal agent of African Sleeping Sickness
(ASS — African Trypanosomiasis) [5]. The latter peptides are being
investigated as an alternative to the traditional therapeutic treat-
ments using arsenical compounds [6], and have shown enhanced
trypanocidal activity due to esteriﬁcation increasing hydrophobicity/
surface activity and enhancing protozoan, cell membrane disruption.
In a recent paper, we showed that antiparasitic peptides were
amenable to formstable Langmuirmonolayers at the air/water interface,
whose surface pressure isotherms displayed a region of negative
compression modulus, in the ﬁrst compression–decompression cycle
[7]. Upon combining information from BAM and PM-IRRAS measure-ments, we concluded that this negative elasticity was ascribed to
aggregation during compression caused by intermolecular associations.
Also in ref. [7], we noted that the peptide induced expansion in the
surface pressure isotherms of dipalmitoyl phosphatidyl choline (DPPC)
monolayers used as a cell membrane model.
In this paper, we investigate the possible generality of action of
these antiparasitic glutathioine peptides on various types of mono-
layermodels thatmaymimic cellmembrane systems. In particular, we
used zwitterionic phospholipids, such as dipalmitoyl phosphatidyl-
ethanolamine (DPPE), in addition to the negatively charged dipalmi-
toyl phosphatidic acid (DPPA) and dipalmitoyl phosphatidyl glycerol
(DPPG), the positively charged dioctadecyldimethylammonium bro-
mide (DODAB), and lipids known to form rafts in cell membranes
(sphingomyelin and cholesterol). The motivation for using the rafts is
that they are relevant for various cell membrane phenomena [8], such
as signaling and cell transport. The methods employed to analyze the
monolayers were surface pressure isotherms and polarization-
modulated infrared reﬂection-absorption spectroscopy (PM-IRRAS).
With the experiments reported here it is possible to extend the
analysis in ref. [7] and show that the conformation of the peptide at the
air/water interface depends on several factors, including its relative
concentration and the lipid composition.
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Fig. 2. Surface pressure-area isotherm for zwitterionic lipids and mixed peptide (2% in
mol)-lipid monolayer. For the x-axis, “area per lipid” means that only lipid molecules
were taken into account in the calculation.
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The compound S-(2,4-dinitrophenyl)glutathioine di-2-propyl ester,
whose chemical structure is shown in Fig. 1, was synthesized as described
in ref. [2]. The lipids DPPC, DPPE, DPPA, DPPG, DODAB, cholesterol and
sphingomyelin were acquired from Avanti Polar Lipids and used without
further puriﬁcation. For preparing Langmuir monolayers, the lipids and
the peptide were dissolved in chloroform (Merck) at a concentration of
0.5 mg/mL. The solutions were spread on an aqueous subphase with pH
7.5 (consistingof 0.1 mol L−1NaCl (Merck), and0.001 mol L−1 phosphate
buffer (Na2HPO4:NaH2PO4=1:1, Merck)). Peptide–lipid mixed mono-
layers were obtained by spreading the drug-containing solution after the
lipidmonolayer hadbeen formed, but at a large area permolecule (at zero
surface pressure). After 10–15 min to allow for solvent evaporation, the
air–water interfacewas compressedwith twomovablebarriers at a rate of
25 cm2 min−1. Areas permoleculewere calculated assuming that all drug
molecules remained at the interface. For mixed drug-lipid monolayers,
use wasmade of the area per lipidmolecule (assuming themolecule was
alone at the interface), in order to better evaluate the changes in the lipid
monolayers induced by the small amounts of the drug (2% inmol or less).
These experiments were performed in a NIMA trough (model 601 M,
subphase volume: 500 mL).
Polarization-Modulated Infrared Reﬂection-Absorption Spectroscopy
(PM-IRRAS)was performedusing aKSVPMI 550 instrument (KSV, Biolin
Scientiﬁc Oy, Helsinki, Finland). The experimental setup was similar to
that described by Blaudez and co-workers [9]. The Langmuir trough
(mini KSV) was mounted so that the light beam reached the monolayer
at a ﬁxed incidence angle of 80°, for which the upward-oriented bands
indicate a transition moment preferentially on the surface plane,
whereas downward-oriented bands indicate preferential orientation
perpendicular to the surface.
All the experiments were carried out in a class 10,000 clean room
at the temperature of 23.0±0.2 °C.
3. Results and discussion
The surface pressure-area isotherm for the pure peptide spread at
the air–water interface was reported in [7], showing a decrease in
pressure upon compression between 70 and 60 Å2. This negative
compressibility modulus was associated with domain formation with
increased lateral ﬂuidity according to Brewster Angle Microscopy
images [7]. The possible reorganization of the peptide molecules at
the interface was discarded on the basis of the PM-IRRAS data, which
supported the hypothesis of a pre-collapse of the monolayer [7].
The set of surface pressure isotherms for the monolayers with
mixed peptide–lipid for 2 mol% of the peptide are shown in Figs. 2–5.
Overall, there is a tendency of the isotherms to expansion at low
surface pressures and in some cases a small condensation in the high
surface pressures (for DPPE andDPPG). Therefore, the peptide appears
to be incorporated in the monolayer at low densities, and be expelled
from the monolayer at high pressures, in some cases even causing the
neighboring lipids to bemore densely packed. Distinctive results wereFig. 1. Chemical structure of the peptide used in this work.obtained for DPPA, which was more expanded than the other
phospholipids (see Fig. 3B), and for cholesterol and cholesterol/
sphingomyelin. For cholesterol, a large condensation was observed at
the condensed phase, but this did not occur when cholesterol was
mixed with sphingomyelin (see Fig. 5). The condensation induced by
cholesterol is consistent with reports in the literature [10], and is
explained by cholesterol's ability to interact with hydrophobic chains
[11,12]. We shall resume the discussion of the effects of adding
sphingomyelin later in the paper. As for the results for DODAB, a
positively charged lipid, the similarity with the data for the
zwitterionic and negatively charged phospholipids means that the
charge of themonolayer-formingmolecules does not appear to exert a
great inﬂuence on monolayer properties. This is not surprising since
the esteriﬁed antiparasitic peptide is not charged and should not be
expected to participate in any type of ionic interaction.
A general feature of the isotherms is that small amounts of the
peptide are sufﬁcient to affect the monolayer, which points to
interaction effects caused by the peptide–lipid interaction as already
observed with other peptides [13,14]. This is illustrated for DPPA in
Fig. 6, while the data for the other lipids are omitted. Signiﬁcantly, the
monolayer condensation at high surface pressures for some lipids
disappears as the amount of peptide is increased. The disappearance
may be caused by the increased area occupied by the drug itself as
higher proportions are used in the mixed monolayers.
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Fig. 3. Surface pressure-area isotherm for negatively charged lipids, and mixed peptide
(2% in mol)-lipid monolayer. For the x-axis, “area per lipid” means that only lipid
molecules were taken into account in the calculation.
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Fig. 4. Surface pressure-area isotherm for a positively charged lipid (DODAB), and
mixed peptide (2% inmol)-lipid monolayer. For the x-axis, the area per lipid means that
only lipid molecules were taken into account in the calculation.
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Fig. 5. Surface pressure-area isotherm for cholesterol and sphingomyelin + cholesterol
mixed monolayer, and mixed peptide (2% in mol)-lipid monolayer. For the x-axis, “area
per lipid” means that only lipid molecules were taken into account in the calculation.
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monolayer, we compared the theoretical and experimental areas per
molecule based on the surface pressure-area for each compound in
themixedmonolayer, for a pressure of 30 mN/m (which is believed to
correspond to the pressure in a real membrane [15]). For obtaining
the theoretical areas, we used the following expression:
A = x1A1 + x2A2
where x1 and x2 are the molar fractions of components 1 and 2,
respectively, and A1 and A2 are the molecular area of each component
inferred from the isotherms of neat components. Fig. 6B shows
positive excess areas, which indicates expansion of themonolayer due
to repulsive interactions or loose molecular accommodation at the
surface. We calculated the excess area for all mixed drug-lipid
monolayers, and the behavior is the same, pointing again to repulsive
interactions between the peptide and the lipid.
Fig. 7 shows the PM-IRRAS spectrum for a Langmuir monolayer of
the pure peptide, which features inverted amide I bands at 1577 cm−1
since the C=O groups lie parallel to the air–water interface, as reported
in [7]. The direction of the band is preserved upon compression, thus
indicating no reorientation. The band at 1677 cm−1 is assigned to
disordered structures, which is reasonable considering the lack of
secondary structure of the small peptide. The amide II band (C–N
vibration) appears at 1521 cm−1.
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Fig. 6. Surface pressure-area isotherm for DPPA and mixed peptide (% in mol indicated
in the insert)-DPPA monolayer. Panel B shows the comparison between the average
molecular areas of the mixed monolayer at 30 mN/m obtained experimentally and
theoretically. The areas from both the lipid and peptide were taken into account. The
excess area may be calculated subtracting the experimental from theoretical values.















Fig. 7. PM-IRRAS spectrum for the peptide monolayer at 0 mN/m. At higher surface
pressures, the bands have their intensity increased with no signiﬁcant change in the
wavenumber position, in agreement with ref. [7].
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shows practically the same behavior for the mixed monolayers
containing 2 mol% of the peptide and DPPC, DPPG or DODAB (the data
for DPPE and DPPA were omitted because they are similar). Again, the
charge state of the phospholipid has no effect on the interaction of the
monolayer with the peptide. The bands appearing in the ﬁgure are
assigned to amide bands. Now, the amide I band is directed upward, in
contrast to the downward direction of the monolayer of the neat
peptide. Therefore, the dipole moment of the amide vibration was
reoriented from a parallel to a perpendicular position in relation to the
air–water interface. This is in contrast with the ﬁnding in our previous
paper [7], for which the peptide appeared not to be reoriented by
DPPC. The discrepancy may be explained by the fact that in the
previous paper the PM-IRRAS measurement was performed for a
mixed monolayer containing 10 mol% of the peptide, and therefore
the peptide molecules in excess maintained their geometrical
orientation as in a pure monolayer. Also, the amide I band has been
split in two peaks at 1640 and 1690 cm−1. The ﬁrst one results from
the re-arrangements of the peptide upon interaction with the lipid
molecules, while that at 1690 cm−1 represents the disordered amide I
band. The latter is shifted to higher energies upon interaction with the
lipid, which means that accommodation of the peptide into the lipid
membrane leads to stable freedom for the C=O vibration moment.
The amide II also appears shifted, at ca. 1555 cm−1, owing to
interaction of C–N vibration with side chains [16].
Signiﬁcant differences were observed in the spectrum for the







































Fig. 8. PM-IRRAS spectra for peptide–lipid (as indicated in the inset) monolayer at
30 mN/m. Raft indicates a mixture of 1:1 cholesterol + sphingomyelin.
1911R.D. Herculano et al. / Biochimica et Biophysica Acta 1808 (2011) 1907–1912where the amide I band is not deconvoluted. It appears as a single
band at 1688 cm−1 with a shoulder at ca. 1650 cm−1, pointing to less
unfolding of the peptide when interacting with cholesterol. It is likely
that interaction with cholesterol makes it easier for the peptide to be
incorporated in the lipid membrane with further accommodation.
Also, for the monolayer simulating roughly a “raft” (sphingomyelin +
cholesterol), the spectra show even more signiﬁcant changes: the
amide I band is downward, with themain peak assigned to disordered
structures shifted to lower energies (1665 cm−1). Also, a band at
1625 cm−1 due to turns for amide bonds appears. This means that the
peptide is not reoriented when incorporated in the “raft” monolayer,
in contrast to the other types of monolayer. Nevertheless, there is still
peptide–lipid interaction leading to ordered structures. This isFig. 9. Schematic model for themolecular orientation for the peptide in: (A) neat monolayer;
up to 2% of peptide; (C) sphingomyelin-cholesterol monolayer containing up to 2% of peptassociated with the peptide molecules being ﬁtted into a compact
monolayer, which does not allow for peptide reorientation in the
membrane.
Overall, themost important result– considering the surface pressure
isotherms and PM-IRRAS spectra – is associated with the fact that a
speciﬁc composition of the monolayer, namely that prepared with
components roughly simulating rafts, provides signiﬁcantly different
results from the other model membrane systems. Not only the
orientation of the peptide at the air/water interface was affected but
also the folding of the peptide was changed leading to the existence of
turns. A scheme depicting the conformation of the peptide is given in
Fig. 9, which depends on the lipid composition of themonolayer, on the
relative peptide concentration and on the surface pressure.(B)monolayer madewith phospholipids possessing two aliphatic chains and containing
ide. The relative sizes of molecules are only illustrative and out-of-scale.
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The behavior of the lipophilic glutathioine peptide at the air/water
interface could be investigated in further detail – in comparison to our
previous work [7] – by using various types of monolayers and
different characterization methods. The main conclusions may be
summarized as follows. The lipophilic glutathioine peptide is able to
affect Langmuir monolayers even at low concentrations at the air/
water interface, thus indicating that interactive effects may be
present. The effects induced on the monolayers do not depend on
the charge of the monolayer-forming molecules for the phospholipids
and DODAB. Particularly important effects were noted, however, for
cholesterol and cholesterol + sphingomyelin monolayers. In choles-
terol monolayers, signiﬁcant condensation was caused by the peptide,
but this did not occur for the mixed cholesterol + sphingomyelin
monolayer. The latter resembles roughly a raft on cell membranes,
and therefore it appears that the most signiﬁcant action by the
peptide should be associated with its interaction with the rafts.
Indeed, while the orientation of the peptide is affected by the
phospholipids and DODAB, with the carbonyl group changing from
perpendicular to the interface for a neat peptide monolayer to a
parallel orientation for the mixed lipid-peptide monolayers, in the
rafts (i.e. cholesterol + sphingomyelin) the orientation of the peptide
is preserved. The implications of these ﬁndings arise from the fact that
the composition of the lipidmonolayermodulates the geometry of the
peptide incorporated into ﬁlm. This may help to understand the
mechanism by which this drug acts on speciﬁc sites of the protozoan
membrane, with molecular-level detail of how the peptide accom-
modates into the membrane model in terms of conformation and
lateral orientation. The data therefore provide a basis for speculating
on effects on the protozoan membrane induced by peptide–lipid
interactions, which may be a key factor for the antiparasitic property
reported for this peptide.Acknowledgements
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